Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eckard Hamelmann

Showing results (1-10 of 200) with videos related to

Pageof 20
Sort By:
Allergo Journal International|November 13, 2018
Long-acting muscarinic antagonists for the treatment of asthma in children-a new kid in townEckard Hamelmann
Biomed Research International|November 27, 2018
Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist TiotropiumEckard Hamelmann
Biomed Research International|March 6, 2019
Corrigendum to "Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium"Eckard Hamelmann
Clinical Allergy and Immunology|October 3, 2008
Anti-IgE therapyEckard Hamelmann, Ulrich Wahn
Clinical Allergy and Immunology|March 27, 2004
Anti-IgE therapyUlrich Wahn, Eckard Hamelmann
Therapeutics and Clinical Risk Management|April 3, 2019
Future perspectives of anticholinergics for the treatment of asthma in adults and childrenRoland Buhl, Eckard Hamelmann
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M|May 4, 2004
Anti-IgE therapy combined with specific immunotherapy: proUlrich Wahn, Eckard Hamelmann
The Journal of Allergy and Clinical Immunology|October 8, 2005
T-cell costimulatory molecules: optimal targets for the treatment of allergic airway disease with monoclonal antibodiesRichard Kroczek, Eckard Hamelmann
Drugs|January 26, 2018
Efficacy and Safety of Tiotropium in Children and AdolescentsEckard Hamelmann, Stanley J Szefler
The Journal of Allergy and Clinical Immunology|February 18, 2003
Corticosteroid treatment in bronchial asthma: for better or for worse?Eckard Hamelmann, Robert P Schleimer
Pageof 20

Showing results (1-10 of 200) with videos related to

Sort By:
Pageof 20
Allergo Journal International|November 13, 2018
Long-acting muscarinic antagonists for the treatment of asthma in children-a new kid in townEckard Hamelmann
Biomed Research International|November 27, 2018
Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist TiotropiumEckard Hamelmann
Biomed Research International|March 6, 2019
Corrigendum to "Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium"Eckard Hamelmann
Clinical Allergy and Immunology|October 3, 2008
Anti-IgE therapyEckard Hamelmann, Ulrich Wahn
Clinical Allergy and Immunology|March 27, 2004
Anti-IgE therapyUlrich Wahn, Eckard Hamelmann
Therapeutics and Clinical Risk Management|April 3, 2019
Future perspectives of anticholinergics for the treatment of asthma in adults and childrenRoland Buhl, Eckard Hamelmann
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M|May 4, 2004
Anti-IgE therapy combined with specific immunotherapy: proUlrich Wahn, Eckard Hamelmann
The Journal of Allergy and Clinical Immunology|October 8, 2005
T-cell costimulatory molecules: optimal targets for the treatment of allergic airway disease with monoclonal antibodiesRichard Kroczek, Eckard Hamelmann
Drugs|January 26, 2018
Efficacy and Safety of Tiotropium in Children and AdolescentsEckard Hamelmann, Stanley J Szefler
The Journal of Allergy and Clinical Immunology|February 18, 2003
Corticosteroid treatment in bronchial asthma: for better or for worse?Eckard Hamelmann, Robert P Schleimer
Pageof 20